Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eila Skinner

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Urologic Oncology|October 4, 2025
Differences in postoperative communication patterns among patients with limited English proficiency following radical cystectomy for bladder cancerAbby L Chen, Chiyuan A Zhang, John Ogunkeye, et al.
European Urology Oncology|February 21, 2023
A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder CancerBrant A Inman, Noah M Hahn, Kelly Stratton, et al.
European Urology|January 26, 2010
Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcomeDerya Tilki, Oliver Reich, Pierre I Karakiewicz, et al.
The Journal of Urology|July 13, 2010
pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladderDerya Tilki, Robert S Svatek, Pierre I Karakiewicz, et al.
Urologia Internationalis|June 11, 2011
Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgeryPhilipp Nuhn, Patrick J Bastian, Giacomo Novara, et al.
The Journal of Urology|March 20, 2010
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patientsDerya Tilki, Oliver Reich, Robert S Svatek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2023
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal LymphadenopathySiamak Daneshmand, Clint Cary, Timothy Masterson, et al.
The Journal of Urology|April 9, 2025
Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS TrialBrian Hu, Muhannad Alsyouf, Ala'a Farkouh, et al.
BJU International|November 20, 2010
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomyGuru Sonpavde, Myrna M Khan, Robert S Svatek, et al.
The Journal of Urology|December 21, 2010
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancerGuru Sonpavde, Myrna M Khan, Seth P Lerner, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Urologic Oncology|October 4, 2025
Differences in postoperative communication patterns among patients with limited English proficiency following radical cystectomy for bladder cancerAbby L Chen, Chiyuan A Zhang, John Ogunkeye, et al.
European Urology Oncology|February 21, 2023
A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder CancerBrant A Inman, Noah M Hahn, Kelly Stratton, et al.
European Urology|January 26, 2010
Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcomeDerya Tilki, Oliver Reich, Pierre I Karakiewicz, et al.
The Journal of Urology|July 13, 2010
pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladderDerya Tilki, Robert S Svatek, Pierre I Karakiewicz, et al.
Urologia Internationalis|June 11, 2011
Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgeryPhilipp Nuhn, Patrick J Bastian, Giacomo Novara, et al.
The Journal of Urology|March 20, 2010
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patientsDerya Tilki, Oliver Reich, Robert S Svatek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2023
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal LymphadenopathySiamak Daneshmand, Clint Cary, Timothy Masterson, et al.
The Journal of Urology|April 9, 2025
Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS TrialBrian Hu, Muhannad Alsyouf, Ala'a Farkouh, et al.
BJU International|November 20, 2010
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomyGuru Sonpavde, Myrna M Khan, Robert S Svatek, et al.
The Journal of Urology|December 21, 2010
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancerGuru Sonpavde, Myrna M Khan, Seth P Lerner, et al.
Pageof 3